Inherited human OX40 deficiency underlying classic kaposi sarcoma of childhood

Journal of Experimental Medicine

Volumn 210, Issue 9, 2013, Pages 1743-1759

  Byun, Minji ^a   Ma Cindy S , C S ^b,c   Akçay, Arzu ^d   Pedergnana, Vincent ^e,f   Palendira, Umaimainthan ^b,c   Myoung, Jinjong ^g   Avery, Danielle T ^b   Liu, Yifang ^h   Abhyankar, Avinash ^a   Lorenzo, Lazaro ^e,f   Schmidt, Monika ⁱ   Lim, Hye Kyung ^a   Cassar, Olivier ^j   Migaud, Melanie ^e,f   Rozenberg, Flore ^k   Canpolat, Nur ^l   Aydogan, Gönül ^d   Fleckenstein, Bernhard ⁱ   Bustamante, Jacinta ^e,f,m   Picard, Capucine ^e,f,m   Gessain, Antoine ^j   Jouanguy, Emmanuelle ^a,e,f   Cesarman, Ethel ^h   Olivier, Martin ⁿ   Gros, Philippe ⁿ   Abel, Laurent ^a,e,f   Croft, Michael ^o   Tangye, Stuart G ^b,c   Casanova, Jean Laurent ^a,e,f,m   more..

^a ROCKEFELLER UNIVERSITY   (United States)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Kanuni Sultan Suleyman Education and Research Hospital   (Turkey)

^e INSERM   (France)

^f IMAGINE INSTITUTE   (France)

^g NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^j INSTITUT PASTEUR   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

^l ISTANBUL UNIVERSITY   (Turkey)

^m HÔPITAL NECKER ENFANTS MALADES   (France)

ⁿ MCGILL UNIVERSITY   (Canada)

^o LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD134 ANTIGEN; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; OX40 LIGAND; TUMOR NECROSIS FACTOR RECEPTOR; VINBLASTINE; VIRUS ANTIBODY;

ADULT; AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; B LYMPHOCYTE DIFFERENTIATION; BLOOD SAMPLING; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CELLULAR IMMUNITY; CHILDHOOD CANCER; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; ENDOTHELIUM CELL; EPSTEIN BARR VIRUS; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN PARVOVIRUS B19; IN VITRO STUDY; IN VIVO STUDY; INTESTINE INJURY; KAPOSI SARCOMA; LEUKOCYTE COUNT; LINKAGE ANALYSIS; LOSS OF FUNCTION MUTATION; MEMORY CELL; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NATURAL KILLER T CELL; ONSET AGE; OX40 DEFICIENCY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; UNFOLDED PROTEIN RESPONSE; VARICELLA ZOSTER VIRUS; VIREMIA; VISCERAL LEISHMANIASIS; WISKOTT ALDRICH SYNDROME;

ADULT; AGE OF ONSET; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODY FORMATION; BASE SEQUENCE; CELL MEMBRANE; CHILD; CYSTEINE; FEMALE; HEK293 CELLS; HOMOZYGOTE; HUMANS; IMMUNOLOGIC MEMORY; INHERITANCE PATTERNS; INTRACELLULAR SPACE; LYMPHOCYTE COUNT; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; RECEPTORS, OX40; SARCOMA, KAPOSI; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84884376772     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130592     Document Type: Article

References (77)

1. Abecasis, G.R., S.S. Cherny, W.O. Cookson, and L.R. Cardon. 2002. Merlin- rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 30:97-101. http://dx.doi.org/10.1038/ng786
2. Adzhubei, I.A., S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, A.S. Kondrashov, and S.R. Sunyaev. 2010. A method and server for predicting damaging missense mutations. Nat. Methods. 7:248-249. http://dx.doi.org/10.1038/nmeth0410-248
3. Akman, E.S., U. Ertem, V. Tankal, A. Pamir, A.M. Tuncer, and O. Uluoglu. 1989. Aggressive Kaposi's sarcoma in children: a case report. Turk. J. Pediatr. 31:297-303.
4. Alcaïs, A., L. Quintana-Murci, D.S. Thaler, E. Schurr, L. Abel, and J.L. Casanova. 2010. Life-threatening infectious diseases of childhood: single- gene inborn errors of immunity? Ann. N. Y. Acad. Sci. 1214:18-33. http://dx.doi.org/10.1111/j.1749-6632.2010.05834.x
5. Andreoni, M., G. El-Sawaf, G. Rezza, B. Ensoli, E. Nicastri, L. Ventura, L. Ercoli, L. Sarmati, and G. Rocchi. 1999. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J. Natl. Cancer Inst. 91:465-469. http://dx.doi.org/ 10.1093/jnci/91.5.465
6. Andreoni, M., L. Sarmati, E. Nicastri, G. El Sawaf, M. El Zalabani, I. Uccella, R. Bugarini, S.G. Parisi, and G. Rezza. 2002. Primary human herpesvirus 8 infection in immunocompetent children. JAMA. 287:1295-1300. http://dx.doi.org/10.1001/jama.287.10.1295
7. Avery, D.T., E.K. Deenick, C.S. Ma, S. Suryani, N. Simpson, G.Y. Chew, T.D. Chan, U. Palendira, J. Bustamante, S. Boisson-Dupuis, et al. 2010. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 207:155-171. http://dx.doi.org/10.1084/jem.20091706
8. Bisceglia, M., M. Amini, and C. Bosman. 1988. Primary Kaposi's sarcoma of the lymph node in children. Cancer. 61:1715-1718. http://dx.doi.org/ 10.1002/1097-0142(19880415)61:81715::AID-CNCR2820610833 3.0.CO;2-P
9. Boettler, T., F. Moeckel, Y. Cheng, M. Heeg, S. Salek-Ardakani, S. Crotty, M. Croft, and M.G. von Herrath. 2012. OX40 facilitates control of a persistent virus infection. PLoS Pathog. 8:e1002913. http://dx.doi .org/10.1371/journal.ppat.1002913
10. Boshoff, C., and R.A. Weiss. 2001. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:517-534. http://dx.doi.org/10.1098/rstb.2000.0778
11. Bryant, V.L., C.S. Ma, D.T. Avery, Y. Li, K.L. Good, L.M. Corcoran, R. de Waal Malefyt, and S.G. Tangye. 2007. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179:8180-8190.
12. Bucheton, B., L. Abel, S. El-Safi, M.M. Kheir, S. Pavek, A. Lemainque, and A.J. Dessein. 2003. A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am. J. Hum. Genet. 73:1052-1060. http://dx.doi.org/10.1086/379084
13. Byun, M., A. Abhyankar, V. Lelarge, S. Plancoulaine, A. Palanduz, L. Telhan, B. Boisson, C. Picard, S. Dewell, C. Zhao, et al. 2010. Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J. Exp. Med. 207:2307-2312. http://dx.doi .org/10.1084/jem.20101597
14. Cabello, P.H., A.M. Lima, E.S. Azevedo, and H. Krieger. 1995. Familial aggregation of Leishmania chagasi infection in northeastern Brazil. Am. J. Trop. Med. Hyg. 52:364-365.
15. Cakir, F.B., E. Cakir, N. Tuzuner, and A. Kut. 2013. Classic Kaposi sarcoma with pulmonary involvement mimicking endobronchial tuberculosis in a child. Pediatr. Pulmonol. 48:310-312. http://dx.doi.org/10.1002/ppul .22635
16. Camcioglu, Y., C. Picard, V. Lacoste, S. Dupuis, N. Akçakaya, H. Cokura, G. Kaner, C. Demirkesen, S. Plancoulaine, J.F. Emile, et al. 2004. HHV-8- associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. J. Pediatr. 144:519-523. http://dx.doi.org/10.1016/j.jpeds.2003.11.012
17. Cann, H.M., C. de Toma, L. Cazes, M.F. Legrand, V. Morel, L. Piouffre, J. Bodmer, W.F. Bodmer, B. Bonne-Tamir, A. Cambon-Thomsen, et al. 2002. A human genome diversity cell line panel. Science. 296:261-262. http://dx.doi.org/10.1126/science.296.5566.261b
18. Casanova, J.L., and L. Abel. 2007. Primary immunodeficiencies: a field in its infancy. Science. 317:617-619. http://dx.doi.org/10.1126/science.1142963
19. Chang, Y., E. Cesarman, M.S. Pessin, F. Lee, J. Culpepper, D.M. Knowles, and P.S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1865-1869. http://dx.doi.org/10.1126/science.7997879
20. Chappuis, F., S. Sundar, A. Hailu, H. Ghalib, S. Rijal, R.W. Peeling, J. Alvar, and M. Boelaert. 2007. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat. Rev. Microbiol. 5:873-882. http://dx.doi.org/10.1038/nrmicro1748
21. Compaan, D.M., and S.G. Hymowitz. 2006. The crystal structure of the costimulatory OX40-OX40L complex. Structure. 14:1321-1330. http://dx.doi.org/10.1016/j.str.2006.06.015
22. Conley, M.E., A.K. Dobbs, D.M. Farmer, S. Kilic, K. Paris, S. Grigoriadou, E. Coustan-Smith, V. Howard, and D. Campana. 2009. Primary B cell immunodeficiencies: comparisons and contrasts. Annu. Rev. Immunol. 27:199-227. http://dx.doi.org/10.1146/annurev.immunol.021908.132649
23. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3:609-620. http://dx.doi.org/10.1038/nri1148
24. Croft, M. 2010. Control of immunity by the TNFR-related molecule OX40 (CD134). Annu. Rev. Immunol. 28:57-78. http://dx.doi.org/10 .1146/annurev-immunol-030409-101243
25. Davidovici, B., I. Karakis, D. Bourboulia, S. Ariad, J. Zong, D. Benharroch, N. Dupin, R. Weiss, G. Hayward, B. Sarov, and C. Boshoff. 2001. Seroepidemiology and molecular epidemiology of Kaposi's sarcomaassociated herpesvirus among Jewish population groups in Israel. J. Natl. Cancer Inst. 93:194-202. http://dx.doi.org/10.1093/jnci/93.3.194
26. de Beaucoudrey, L., A. Samarina, J. Bustamante, A. Cobat, S. Boisson-Dupuis, J. Feinberg, S. Al-Muhsen, L. Jannière, Y. Rose, M. de Suremain, et al. 2010. Revisiting human IL-12R?1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore). 89:381-402. http://dx.doi.org/10.1097/MD.0b013e3181fdd832
27. Duhen, T., R. Duhen, A. Lanzavecchia, F. Sallusto, and D.J. Campbell. 2012. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood. 119:4430-4440. http://dx.doi.org/10.1182/blood-2011-11-392324
28. Dutz, W., and A.P. Stout. 1960. Kaposi's sarcoma in infants and children. Cancer. 13:684-694. http://dx.doi.org/10.1002/1097-0142(196007/08) 13:4684::AID-CNCR28201304083.0.CO;2-G
29. Ferrari, A., M. Casanova, G. Bisogno, G. Cecchetto, C. Meazza, L. Gandola, A. Garaventa, A. Mattke, J. Treuner, and M. Carli. 2002. Malignant vascular tumors in children and adolescents: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. Med. Pediatr. Oncol. 39:109-114. http://dx.doi.org/10.1002/mpo.10078
30. Fuchs, S., A. Rensing-Ehl, C. Speckmann, B. Bengsch, A. Schmitt-Graeff, I. Bondzio, A. Maul-Pavicic, T. Bass, T. Vraetz, B. Strahm, et al. 2012. Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. J. Immunol. 188:1523-1533. http://dx.doi.org/10.4049/jimmunol.1102507
31. Ganem, D. 2010. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 120:939-949. http://dx.doi.org/10.1172/JCI40567
32. Gessain, A., P. Mauclère, M. van Beveren, S. Plancoulaine, A. Ayouba, J.L. Essame-Oyono, P.M. Martin, and G. de Thé. 1999. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int. J. Cancer. 81:189-192. http://dx.doi.org/10.1002/(SICI) 1097-0215(19990412)81:2189::AID-IJC43.0.CO;2-E
33. Gramaglia, I., A. Jember, S.D. Pippig, A.D. Weinberg, N. Killeen, and M. Croft. 2000. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J. Immunol. 165:3043-3050.
34. Hendriks, J., Y. Xiao, J.W. Rossen, K.F. van der Sluijs, K. Sugamura, N. Ishii, and J. Borst. 2005. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J. Immunol. 175:1665-1676.
35. Hislop, A.D., U. Palendira, A.M. Leese, P.D. Arkwright, P.S. Rohrlich, S.G. Tangye, H.B. Gaspar, A.C. Lankester, A. Moretta, and A.B. Rickinson. 2010. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets. Blood. 116:3249-3257. http://dx.doi.org/10.1182/blood- 2009-09-238832
36. Humphreys, I.R., A. Loewendorf, C. de Trez, K. Schneider, C.A. Benedict, M.W. Munks, C.F. Ware, and M. Croft. 2007. OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4- dependent mechanism. J. Immunol. 179:2195-2202.
37. Hussein, M.R. 2008. Cutaneous and lymphadenopathic Kaposi's sarcoma: a case report and review of literature. J. Cutan. Pathol. 35:575-578. http://dx.doi.org/10.1111/j.1600-0560.2007.00844.x
38. Ibrahim, M.E., B. Lambson, A.O. Yousif, N.S. Deifalla, D.A. Alnaiem, A. Ismail, H. Yousif, H.W. Ghalib, E.A. Khalil, A. Kadaro, et al. 1999. Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am. J. Trop. Med. Hyg. 61:941-944.
39. Imura, A., T. Hori, K. Imada, T. Ishikawa, Y. Tanaka, M. Maeda, S. Imamura, and T. Uchiyama. 1996. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 183:2185-2195. http://dx.doi.org/10.1084/jem.183.5.2185
40. Iscovich, J., P. Boffetta, S. Franceschi, E. Azizi, and R. Sarid. 2000. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer. 88:500-517. http://dx.doi.org/10.1002/(SICI)1097-0142(20000201)88:3500::AID-CNCR33.0 .CO;2-9
41. Jensen, P., S. Hansen, B. Møller, T. Leivestad, P. Pfeffer, O. Geiran, P. Fauchald, and S. Simonsen. 1999. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J. Am. Acad. Dermatol. 40:177-186. http://dx.doi.org/10.1016/S0190-9622(99)70185-4
42. Kaposi, M. 1872. Idiopathisches multiples pigmentsarcom der haut. Arch Dermatol und Syphillis. 4:265-273.
43. Khalil, E.A., E.E. Zijlstra, P.A. Kager, and A.M. El Hassan. 2002. Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. Trop. Med. Int. Health. 7:35-44. http://dx.doi.org/10.1046/j.1365-3156.2002.00832.x
44. Kopf, M., C. Ruedl, N. Schmitz, A. Gallimore, K. Lefrang, B. Ecabert, B. Odermatt, and M.F. Bachmann. 1999. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. Immunity. 11:699-708. http://dx.doi.org/10.1016/S1074-7613(00)80144-2
45. Kumar, P., S. Henikoff, and P.C. Ng. 2009. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4:1073-1081. http://dx.doi.org/10.1038/nprot.2009.86
46. Kumar, R., and S. Nylén. 2012. Immunobiology of visceral leishmaniasis. Front Immunol. 3:251.
47. Kunitomi, A., T. Hori, A. Imura, and T. Uchiyama. 2000. Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system. J. Leukoc. Biol. 68:111-118.
48. Landau, H.J., B.J. Poiesz, S. Dube, J.A. Bogart, L.B. Weiner, and A.K. Souid. 2001. Classic Kaposi's sarcoma associated with human herpesvirus 8 infection in a 13-year-old male: a case report. Clin. Cancer Res. 7:2263-2268.
49. Lebbé, C., C. Legendre, and C. Francès. 2008. Kaposi sarcoma in transplantation. Transplant. Rev. (Orlando). 22:252-261. http://dx.doi.org/10 .1016/j.trre.2008.05.004
50. Li, H., and R. Durbin. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25:1754-1760. http://dx.doi.org/10.1093/bioinformatics/btp324
51. Li, H., B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, and R. Durbin; 1000 Genome Project Data Processing Subgroup. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 25:2078-2079. http://dx.doi.org/10.1093/bioinformatics/btp352
52. Mayama, S., L.E. Cuevas, J. Sheldon, O.H. Omar, D.H. Smith, P. Okong, B. Silvel, C.A. Hart, and T.F. Schulz. 1998. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int. J. Cancer. 77:817-820. http://dx .doi.org/10.1002/(SICI)1097-0215(19980911)77:6817::AID-IJC23 .0.CO;2-X
53. McKenna, A.H., M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. Kernytsky, K. Garimella, D. Altshuler, S. Gabriel, M. Daly, and M.A. DePristo. 2010. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20:1297-1303. http://dx.doi.org/10.1101/gr.107524.110
54. Michel, G., C. Pomares, B. Ferrua, and P. Marty. 2011. Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Trop. 119:69-75. http://dx.doi.org/10.1016/j.actatropica.2011.05.012
55. Morimoto, S., Y. Kanno, Y. Tanaka, Y. Tokano, H. Hashimoto, S. Jacquot, C. Morimoto, S.F. Schlossman, H. Yagita, K. Okumura, and T. Kobata. 2000. CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses. J. Immunol. 164: 4097-4104.
56. Murray, H.W. 1999. Kala-azar as an AIDS-related opportunistic infection. AIDS Patient Care STDS. 13:459-465. http://dx.doi.org/10.1089/108729199318183
57. Olweny, C.L., A. Kaddumukasa, I. Atine, R. Owor, I. Magrath, and J.L. Ziegler. 1976. Childhood Kaposi's sarcoma: clinical features and therapy. Br. J. Cancer. 33:555-560. http://dx.doi.org/10.1038/bjc.1976.88
58. Palendira, U., C. Low, A. Chan, A.D. Hislop, E. Ho, T.G. Phan, E. Deenick, M.C. Cook, D.S. Riminton, S. Choo, et al. 2011. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol. 9:e1001187. http://dx.doi.org/10.1371/journal.pbio.1001187
59. Palendira, U., C. Low, A.I. Bell, C.S. Ma, R.J. Abbott, T.G. Phan, D.S. Riminton, S. Choo, J.M. Smart, V. Lougaris, et al. 2012. Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus. J. Exp. Med. 209:913-924. http://dx.doi.org/10.1084/jem.20112391
60. Papadopoulos, C., G. Terzis, G.K. Papadimas, and P. Manta. 2013. OX40- OX40L expression in idiopathic inflammatory myopathies. Anal. Quant. Cytol. Histol. 35:17-26.
61. Picard, C., F. Mellouli, R. Duprez, G. Chédeville, B. Neven, S. Fraitag, J. Delaunay, F. Le Deist, A. Fischer, S. Blanche, et al. 2006. Kaposi's sarcoma in a child with Wiskott-Aldrich syndrome. Eur. J. Pediatr. 165:453-457. http://dx.doi.org/10.1007/s00431-006-0107-2
62. Pippig, S.D., C. Peña-Rossi, J. Long, W.R. Godfrey, D.J. Fowell, S.L. Reiner, M.L. Birkeland, R.M. Locksley, A.N. Barclay, and N. Killeen. 1999. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40). J. Immunol. 163:6520-6529.
63. Plancoulaine, S., L. Abel, M. van Beveren, D.A. Trégouët, M. Joubert, P. Tortevoye, G. de Thé, and A. Gessain. 2000. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet. 356:1062-1065. http://dx.doi.org/10.1016/S0140-6736(00) 02729-X
64. Plancoulaine, S., L. Abel, and A. Gessain. 2002. [Epidemiology of human herpes virus 8 (HHV-8) or the herpes virus associated with Kaposi's sarcoma (KSHV)]. Pathol. Biol. (Paris). 50:496-502. http://dx.doi.org/10.1016/S0369-8114(02)00317-6
65. Sahin, G., A. Palanduz, G. Aydogan, O. Cassar, A.U. Ertem, L. Telhan, N. Canpolat, E. Jouanguy, C. Picard, A. Gessain, et al. 2010. Classic Kaposi sarcoma in 3 unrelated Turkish children born to consanguineous kindreds. Pediatrics. 125:e704-e708. http://dx.doi.org/10.1542/peds .2009-2224
66. Salek-Ardakani, S., M. Moutaftsi, S. Crotty, A. Sette, and M. Croft. 2008. OX40 drives protective vaccinia virus-specific CD8 T cells. J. Immunol. 181:7969-7976.
67. Salem, H.A., M. El Sohafy, and M. Abd El Gawad. 2011. Kaposi's sarcoma in an atopic dermatitis patient: a case report and a review of literature. Pediatr. Dermatol. 28:547-549. http://dx.doi.org/10.1111/j.1525-1470.2011. 01347.x
68. Sanal, O., G. Turkkani, F. Gumruk, L. Yel, G. Secmeer, I. Tezcan, A. Kara, and F. Ersoy. 2007. A case of interleukin-12 receptor beta-1 deficiency with recurrent leishmaniasis. Pediatr. Infect. Dis. J. 26:366-368. http://dx.doi. org/10.1097/01.inf.0000258696.64507.0f
69. Schoggins, J.W., S.J. Wilson, M. Panis, M.Y. Murphy, C.T. Jones, P. Bieniasz, and C.M. Rice. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 472:481-485. http://dx.doi.org/10.1038/nature09907
70. Serraino, D., P. Piselli, C. Angeletti, E. Minetti, A. Pozzetto, G. Civati, S. Bellelli, F. Farchi, F. Citterio, G. Rezza, et al. 2005. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br. J. Cancer. 92:572-575.
71. Shiels, M.S., R.M. Pfeiffer, M.H. Gail, H.I. Hall, J. Li, A.K. Chaturvedi, K. Bhatia, T.S. Uldrick, R. Yarchoan, J.J. Goedert, and E.A. Engels. 2011. Cancer burden in the HIV-infected population in the United States. J. Natl. Cancer Inst. 103:753-762. http://dx.doi.org/10.1093/jnci/djr076
72. Souza, H.S., C.C. Elia, J. Spencer, and T.T. MacDonald. 1999. Expression of lymphocyte- endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut. 45:856-863. http://dx.doi.org/10.1136/gut.45.6.856
73. Taylor, J.F., P.G. Smith, D. Bull, and M.C. Pike. 1972. Kaposi's sarcoma in Uganda: geographic and ethnic distribution. Br. J. Cancer. 26:483-497. http://dx.doi.org/10.1038/bjc.1972.66
74. Wang, Q.J., F.J. Jenkins, L.P. Jacobson, L.A. Kingsley, R.D. Day, Z.W. Zhang, Y.X. Meng, P.E. Pellett, K.G. Kousoulas, A. Baghian, and C.R. Rinaldo Jr. 2001. Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood. 97:2366-2373. (published erratum appears in Blood. 2002. 99:3499) http://dx.doi.org/10.1182/blood.V97.8.2366
75. Weinberg, A.D., N.P. Morris, M. Kovacsovics-Bankowski, W.J. Urba, and B.D. Curti. 2011. Science gone translational: the OX40 agonist story. Immunol. Rev. 244:218-231. http://dx.doi.org/10.1111/j.1600-065X.2011.01069.x
76. Zubairi, S., S.L. Sanos, S. Hill, and P.M. Kaye. 2004. Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani. Eur. J. Immunol. 34:1433-1440. http://dx .doi.org/10.1002/eji.200324021
77. Zurrida, S., R. Agresti, and G. Cefalo. 1994. Juvenile classic Kaposi's sarcoma: a report of two cases, one with family history. Pediatr. Hematol. Oncol. 11:409-416. http://dx.doi.org/10.3109/08880019409140540